Cargando…

Effect of acetic acid inactivation of SARS-CoV-2

Effective measures are needed to prevent the spread and infectivity of SARS-CoV-2 that causes COVID-19. Chemical inactivation may help to prevent the spread and transmission of this and other viruses. Hence, we tested the SARS-CoV-2 antiviral activity of acetic acid, the main component of vinegar, i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amruta, Narayanappa, Maness, Nicholas J., Gressett, Timothy E., Tsuchiya, Yoshihiro, Kishi, Mikiya, Bix, Gregory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907812/ https://www.ncbi.nlm.nih.gov/pubmed/36753524 http://dx.doi.org/10.1371/journal.pone.0276578

Ejemplares similares

Mouse Adapted SARS-CoV-2 (MA10) Viral Infection Induces Neuroinflammation in Standard Laboratory Mice
por: Amruta, Narayanappa, et al.
Publicado: (2022)

In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice
por: Amruta, Narayanappa, et al.
Publicado: (2021)

SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
por: Amruta, Narayanappa, et al.
Publicado: (2021)

Integrins as Therapeutic Targets for SARS-CoV-2
por: Gressett, Timothy E., et al.
Publicado: (2022)

ATN-161 Ameliorates Ischemia/Reperfusion-induced Oxidative Stress, Fibro-inflammation, Mitochondrial damage, and Apoptosis-mediated Tight Junction Disruption in bEnd.3 Cells
por: Amruta, Narayanappa, et al.
Publicado: (2021)

Neurogenesis After Stroke: A Therapeutic Perspective
por: Rahman, Abir A., et al.
Publicado: (2020)

Perlecan: a review of its role in neurologic and musculoskeletal disease
por: Lavorgna, Tessa R., et al.
Publicado: (2023)

In the Age of COVID: Genomic Changes Over the Lifespan Help Explain Severe SARS-CoV-2 Disease
por: Beddingfield, Brandon J., et al.
Publicado: (2020)

Assessment of inactivation procedures for SARS-CoV-2
por: Auerswald, Heidi, et al.
Publicado: (2021)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine
por: Wilder-Smith, Annelies, et al.
Publicado: (2021)

Inactivation of SARS-CoV-2 by gamma irradiation
por: Jain, Rajlaxmi, et al.
Publicado: (2021)

Inactivating SARS-CoV-2 by electrochemical oxidation
por: Tu, Yunchuan, et al.
Publicado: (2021)

Inactivation of SARS-CoV-2 Laboratory Specimens
por: Haddock, Elaine, et al.
Publicado: (2021)

Inactivation of SARS-CoV-2 by Ozonated Glycerol
por: Takeda, Yohei, et al.
Publicado: (2021)

PMMA Microcapsules for the Inactivation of SARS-CoV-2
por: Sousa, Vânia I., et al.
Publicado: (2022)

Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates
por: Rutkai, Ibolya, et al.
Publicado: (2022)

Thermal inactivation and nucleic acid amplification-based testing for SARS-CoV-2
por: Péré, Hélène, et al.
Publicado: (2020)

Hypochlorous acid inactivates oral pathogens and a SARS-CoV-2-surrogate
por: Tazawa, Kento, et al.
Publicado: (2023)

Acetate-encapsulated Linolenic Acid Liposomes Reduce SARS-CoV-2 and RSV Infection
por: McGill, Andrew R., et al.
Publicado: (2023)

Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces
por: Ratnesar-Shumate, Shanna, et al.
Publicado: (2020)

Airborne SARS-CoV-2 Is Rapidly Inactivated by Simulated Sunlight
por: Schuit, Michael, et al.
Publicado: (2020)

Yellow Pea Pasta Enhances the Saltiness and Suppression of Postprandial Blood Glucose Elevation
por: Tsuchiya, Yoshihiro, et al.
Publicado: (2023)

Growth, detection, quantification, and inactivation of SARS-CoV-2
por: Case, James Brett, et al.
Publicado: (2020)

Propagation, Inactivation, and Safety Testing of SARS-CoV-2
por: Jureka, Alexander S., et al.
Publicado: (2020)

Cold atmospheric plasma for SARS-CoV-2 inactivation
por: Chen, Zhitong, et al.
Publicado: (2020)

Thermal inactivation scaling applied for SARS-CoV-2
por: Seifer, Shahar, et al.
Publicado: (2021)

Development of an inactivated vaccine candidate for SARS-CoV-2
por: Gao, Qiang, et al.
Publicado: (2020)

Development of an Inactivated Vaccine against SARS CoV-2
por: Pavel, Shaikh Terkis Islam, et al.
Publicado: (2021)

Rapid thermal inactivation of aerosolized SARS-CoV-2
por: Canpolat, Murat, et al.
Publicado: (2022)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

SARS-CoV-2 is rapidly inactivated at high temperature
por: Biryukov, Jennifer, et al.
Publicado: (2021)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
por: Jara, Alejandro, et al.
Publicado: (2021)

Effectiveness of near-UVA in SARS-CoV-2 inactivation
por: Frilli, Eleonora, et al.
Publicado: (2023)

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2021)

The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2
por: Akhter, Javed, et al.
Publicado: (2021)

Quantitative evaluation of SARS-CoV-2 inactivation using a deep ultraviolet light-emitting diode
por: Minamikawa, Takeo, et al.
Publicado: (2021)

Guillain‐Barré syndrome after SARS‐CoV‐2 infection
por: Kajita, Mikiya, et al.
Publicado: (2021)

Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
por: Luo, Fan, et al.
Publicado: (2018)

Methods of Inactivation of SARS-CoV-2 for Downstream Biological Assays
por: Patterson, Edward I, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_38r2tn3e9f9fvn8urr8gh5b17m